Willis Towers Watson Publ... (WLTW)
NASDAQ: WLTW
· Real-Time Price · USD
231.56
-2.78 (-1.19%)
At close: Jan 10, 2022, 6:00 AM
Willis Towers Watson Public Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Health, Wealth and Career Revenue | 5.85B | 5.66B | 5.35B |
| Health, Wealth and Career Revenue Growth | +3.38% | +5.68% | n/a |
| Risk and Broking Revenue | 4.05B | 3.75B | 3.47B |
| Risk and Broking Revenue Growth | +8.08% | +7.98% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Revenue | 9.8B | 9.37B | 8.74B | 8.8B | 9.2B | 8.89B | 8.38B | 8.1B | 92M | 1.07B | 1.02B | 1.08B | 1.04B | 1.46B |
| International Revenue Growth | +4.63% | +7.20% | -0.74% | -4.28% | +3.37% | +6.21% | +3.46% | +8698.91% | -91.39% | +4.50% | -5.19% | +3.85% | -28.95% | n/a |
| Ireland Revenue | 131M | 118M | 130M | 1.63B | 157M | 144M | 138M | 107M | 2.16B | n/a | n/a | n/a | n/a | n/a |
| Ireland Revenue Growth | +11.02% | -9.23% | -92.03% | +939.49% | +9.03% | +4.35% | +28.97% | -95.06% | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue | 2.81B | 2.63B | 2.41B | 197M | 2.63B | 2.59B | 2.48B | 2.46B | 3.4B | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue Growth | +6.88% | +9.03% | +1124.87% | -92.50% | +1.31% | +4.52% | +0.81% | -27.57% | n/a | n/a | n/a | n/a | n/a | n/a |
| United Kingdom Revenue | 1.86B | 1.72B | 1.56B | 2.55B | 1.92B | 1.93B | 1.93B | 1.81B | n/a | n/a | n/a | n/a | n/a | n/a |
| United Kingdom Revenue Growth | +7.89% | +10.24% | -38.66% | +32.71% | -0.72% | +0.42% | +6.12% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 5.13B | 5.01B | 4.76B | 4.62B | 4.65B | 4.37B | 3.97B | 3.82B | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +2.33% | +5.27% | +3.01% | -0.62% | +6.41% | +10.08% | +3.90% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | 54M | n/a | n/a | n/a | -29M | -25M | 46M | 45M | 46M | 72M | 57M | 52M | 56M | 59M | 59M | 59M | 60M | 59M | 57M | 61M | 59M | 63M | 61M | 57M | 58M | 64M | 64M | 302M | n/a | n/a | n/a | 302M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | -100.00% | +16.00% | -154.35% | +2.22% | -2.17% | -36.11% | +26.32% | +9.62% | -7.14% | -5.08% | 0.00% | 0.00% | -1.67% | +1.69% | +3.51% | -6.56% | +3.39% | -6.35% | +3.28% | +7.02% | -1.72% | -9.38% | 0.00% | -78.81% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |